Industry Leaders’ Panel Discussion: Overcoming the Challenges of Toxicity, Extrahepatic Delivery & Scaling-Up in LNP Development to Accelerate a Wider Range of Therapeutics towards the Clinic
Time: 8:30 am
day: Day One
Details:
• Uncovering the strategies for achieving specific, extrahepatic delivery with LNPs
• Delving into approaches for improving therapeutic index, reducing toxicity, and achieving better translatability for safer LNPs
• Highlighting methods for improving LNP and payload stability for better therapeutic development
• Achieving scalability of LNPs which can be used for extrahepatic purposes and unlocking the strategies for maintaining key product attributes